pinaverium bromide

PreclinicalSmall molecule

SSeoul National University Hospital

pinaverium bromide is one of 26 small molecule programs targeting Pancreatitis. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PancreatitisActive, not recruiting

PancreatitisPreclinical

Active, not recruiting

Competition

Competitive Landscape

33 competitors in Pancreatitis

#DrugCompanyPhaseTrials

Indocin

CCosette Pharmaceuticals, Inc.

Approved

23 2

Voltaren

Novartis

Approved

5 3

Cysteine Hydrochloride

Novartis

Approved

1 4

Doribax

Shionogi

Approved

—5

Avycaz

PPhiladelphia Eye Associates

Approved

1 6

Nitrostat

VViatris Specialty LLC

Approved

1 7

Imuran

LLegacy Health System

Approved

1 8

Acetadote

AArbor Pharmaceuticals, Inc.

Approved

—9

Esbriet

LLegacy Health System

Approved

—10

Trental

VValidus Pharmaceuticals

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Pancreatitis1 trial

Pinaverium Bromide Preventing Post Extracorporeal Shock Wave Lithotripsy Pancreatitis and Painful (PBPEP)

Enrolling by invitation·YYanqing Li·N/A·NCT06936800·288 enrolled

Trial1 trial

Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose)

Completed·SSeoul National University Hospital·Phase 4·NCT02173964·58 enrolled

Cholecystectomy1 trial

Pinaverium Bromide in Post-cholecystectomy Sphincter of Oddi Dysfunction

Unknown status·XXinhua Hospital, Shanghai Jiao Tong University School of Medicine·Phase 4·NCT02833103·168 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for pinaverium bromide. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — pinaverium bromide compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for pinaverium bromide. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Seoul National University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SSeoul National University Hospital

pinaverium bromide

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Pancreatitis1 trial

Trial1 trial

Cholecystectomy1 trial

References

Drug Info

Quick Facts

Related News